New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
10:00 EDTYUM, MCD, JBT, ICPT, BERY, OVSC, DNDNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Dendreon (DNDN) initiated with a Buy at Needham... OvaScience (OVSC) initiated with an Outperform at Leerink... Intercept Pharmaceuticals (ICPT) initiated with a Buy at BofA/Merrill... Berry Plastics (BERY) initiated with an Outperform at Wells Fargo... McDonald's (MCD) initiated with a Buy at Davenport... Yum! Brands (YUM) initiated with a Buy at Davenport... JBT Corporation (JBT) initiated with a Buy at Sidoti.
News For DNDN;OVSC;BERY;ICPT;MCD;YUM;JBT From The Last 14 Days
Check below for free stories on DNDN;OVSC;BERY;ICPT;MCD;YUM;JBT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 22, 2014
09:16 EDTMCDOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
08:08 EDTMCDMcDonald's says Q1 results in U.S. reflect negative comparable guest traffic
Subscribe for More Information
08:06 EDTMCDMcDonald's says it is focused on stabilizing key markets
Subscribe for More Information
08:02 EDTMCD McDonald's reports Q1 global comp sales up 0.5%
Reports Q1 U.S. comp sales down 1.7%; Reports Q1 Europe comp sales up 1.4%; Reports Q1 Asia/Pacific, Mideast, Africa comp sales up 0.8%
08:01 EDTMCDMcDonald's expects April global comparable sales to be 'modestly positive'
07:58 EDTMCDMcDonald's reports Q1 EPS $1.21, consensus $1.24
Reports Q1 revenue $6.70B, consensus $6.73B
April 21, 2014
15:16 EDTMCDNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Comcast (CMCSA), consensus 64c; United Technologies (UTX), consensus $1.27; McDonald's (MCD), consensus $1.24; Simon Property Group (SPG), consensus $2.24; Lockheed Martin (LMT), consensus $2.53; Bank of New York Mellon (BK), consensus 53c; Illinois Tool Works (ITW), consensus 98c; Travelers (TRV), consensus $2.16; Omnicom Group (OMC), consensus 79c; Pentair (PNR), consensus 73c; Harley-Davidson (HOG), consensus $1.08; Regions Financial (RF), consensus 20c; Genuine Parts Company (GPC), consensus $1.02; Xerox (XRX), consensus 24c; Carlisle (CSL), consensus 53c.
14:04 EDTYUMYum! Brands Apr 65 weekly straddle priced for 4.4% movement into Q1
Subscribe for More Information
12:51 EDTMCDEarnings Preview: McDonald's shares up more than 3% year-to-date
McDonald's (MCD) is scheduled to report first quarter earnings before the open on Tuesday, April 22, with a conference call scheduled for 11:00 am ET. McDonald’s franchises and operates fast food restaurants globally. EXPECTATIONS: Analysts are looking for earnings per share of $1.24 on revenue of $6.73B, according to First Call. The consensus range for EPS is $1.20-$1.29 on revenue of $6.61B-$6.99B. LAST QUARTER: McDonald's reported fourth quarter EPS of $1.40 against estimates of $1.39 and revenue of $7.09B against estimates of $7.11B. McDonald's also reported global comparable sales down 0.1%, with U.S. SSS down 1.4%, Europe SSS up 1% and Asia/Pacific, Mideast, Africa SSS down 2.4%. On its conference call, the company said it expects to return $5B to shareholders in 2014 through dividends and share repurchases. The company gave fiscal year 2014 guidance for capital expenditures of $2.9B-$3.B, and said the investment will provide for 1,500-1,600 new restaurant openings and the reimaging of over 1,000 existing locations. McDonald's also forecast FY14 commodity costs up 1%-2% in the U.S. NEWS: During the quarter, McDonald's announced that Chief Operating Officer Tim Fenton will retire, effective October 1. He will serve as COO during a brief transition period, and then as a special advisor to Chief Executive Officer Don Thompson. The company will not replace the COO role, but will broaden responsibilities for Pete Bensen, Executive Vice President and Chief Financial Officer, and Steve Easterbrook, Executive Vice President and Global Chief Brand Officer. At the RBC Capital Markets Consumer & Retail Conference in March, CFO Bensen said the U.S. has the "most need" for improvement in the short-term and that the company is looking for ways to optimize capital structure while maintaining long-term financial strength. Bensen previously indicated that the company could raise its target of returning $5B to shareholders if the company increased its leverage. McDonald's also faced lawsuits during the quarter around the country claiming the restaurant chain was "systematically" stealing employees' wages, Reuters reported. PRICE ACTION: McDonald's shares are trading up over 5% over the last three months and are up over 3% year-to-date.
10:01 EDTYUMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:44 EDTYUM, MCDCompetitors gaining ground on McDonald's breakfast market, WSJ says
McDonald's (MCD) faces increased competition from Yum Brands' (YUM) new Taco Bell breakfast menu as well as Burger King (BKW), Dunkin' Brands (DD), Starbucks (SBUX), and White Castle's renewed efforts to gain ground in the breakfast market, reports the Wall Street Journal. Reference Link
06:34 EDTMCDMcDonald's planning makeover for China restaurants, WSJ reports
McDonald's is planning to overhaul some restaurants in China's big cities and add commercials featuring basketball star LeBron James, the Wall Street Journal reports. Reference Link
05:38 EDTYUMYum! Brands downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Yum! Brands to Neutral citing valuation as it believes shares are already pricing in a China recovery through FY15. The firm raised its price target for shares to $80 from $77.
April 15, 2014
09:47 EDTJBTJBT announces U.S. Air Force contracts for Halvorsen 25K services
Subscribe for More Information
April 14, 2014
09:46 EDTJBTJBT Corporation announces $6M juice processing contract in India
JBT Corporation announced that its JBT FoodTech business signed a contract valued in excess of $6M with Citrus Processing India Pvt. JBT FoodTech will supply and integrate a new juice processing line for the production of citrus juice products in India. The order was received in the Q1 with the project currently scheduled to be operational in the 1Q15.
08:59 EDTICPTOn The Fly: Pre-market Movers
Subscribe for More Information
07:23 EDTYUMJapan sees first bird flu outbreak since 2011, Mainichi reports
Subscribe for More Information
April 12, 2014
20:04 EDTICPTIntercept reports additional positive data from POISE trial at EASL
Subscribe for More Information
April 11, 2014
09:08 EDTICPTIntercept announces OCA preclinical study data
Subscribe for More Information
07:01 EDTDNDNDendreon: Immune responses enhanced when Provenge given after ADT
Dendreon Corporation announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when PROVENGE is given after androgen deprivation therapy in patients with biochemically-recurrent prostate cancer at high risk for metastases. These data will be presented at the 29th Annual European Association of Urology Congress taking place from April 11-15, 2014 in Stockholm, Sweden.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use